Orladeyo is now available in Saskatchewan

For people with HAE in Saskatchewan who have been waiting to have access to the first oral preventative treatment, the wait is OVER!

We are thrilled to share that ORLADEYO (berotralstat) has been officially listed on the Saskatchewan Formulary as of May 1, 2025. This inclusion means that Orladeyo is now covered under the Saskatchewan Drug Plan for the routine prevention of attacks of HAE Type I & II in patients aged 12 and older. For further details, please visit the Saskatchewan Formulary Bulletin.

To learn how you can gain access, please speak with your HAE treating physician or contact the EMPOWER Patient Services Program.

You can reach EMPOWER via:

Phone: 1-877-783-MPWR (1-877-783-6797)